Michael Barbella, Managing Editor08.21.23
SetPoint Medical has appointed Rohan Seth as chief financial officer (CFO).
“I am excited to welcome Rohan to the SetPoint leadership team,” SetPoint Medical President/CEO Murthy Simhambhatla, Ph.D., said. “Rohan’s track record of success in managing finance and business development functions will be instrumental as we continue to advance our therapeutic platform through clinical development.”
Prior to SetPoint Medical, Seth was CFO at Cutera, a provider of aesthetic and dermatology solutions. His prior experiences include vice president of Finance for the Global Orthopaedics Franchise at Smith+Nephew plc, head of Finance for U.S. Surgical at Alcon Labs and various roles with increasing responsibilities at Stryker Corporation. Seth started his career in public accounting in Mumbai, India, and worked at the Whirlpool Corporation before his medical device industry roles.
Seth earned his MBA from the University of Notre Dame’s Mendoza College of Business and completed his bachelor of commerce in accounting and auditing from the University of Mumbai’s M. M. K. College of Economics and Commerce. He is also a chartered accountant from the Institute of Chartered Accountants of India.
“I am honored to join the SetPoint team and strongly believe in the amazing value creation and life-changing therapeutic potential it offers for treatment of rheumatoid arthritis,” Seth stated. “I look forward to working with the team to advance the company’s strategy and operational plans.”
SetPoint Medical is a privately held clinical-stage company dedicated to treating patients with chronic autoimmune diseases. The company is developing a platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. SetPoint Medical’s platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions with potentially less risk and cost than drug therapy.
“I am excited to welcome Rohan to the SetPoint leadership team,” SetPoint Medical President/CEO Murthy Simhambhatla, Ph.D., said. “Rohan’s track record of success in managing finance and business development functions will be instrumental as we continue to advance our therapeutic platform through clinical development.”
Prior to SetPoint Medical, Seth was CFO at Cutera, a provider of aesthetic and dermatology solutions. His prior experiences include vice president of Finance for the Global Orthopaedics Franchise at Smith+Nephew plc, head of Finance for U.S. Surgical at Alcon Labs and various roles with increasing responsibilities at Stryker Corporation. Seth started his career in public accounting in Mumbai, India, and worked at the Whirlpool Corporation before his medical device industry roles.
Seth earned his MBA from the University of Notre Dame’s Mendoza College of Business and completed his bachelor of commerce in accounting and auditing from the University of Mumbai’s M. M. K. College of Economics and Commerce. He is also a chartered accountant from the Institute of Chartered Accountants of India.
“I am honored to join the SetPoint team and strongly believe in the amazing value creation and life-changing therapeutic potential it offers for treatment of rheumatoid arthritis,” Seth stated. “I look forward to working with the team to advance the company’s strategy and operational plans.”
SetPoint Medical is a privately held clinical-stage company dedicated to treating patients with chronic autoimmune diseases. The company is developing a platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. SetPoint Medical’s platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions with potentially less risk and cost than drug therapy.